A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
National Comprehensive Cancer Network Guideline for Non-Small Cell Lung Cancer, version 8. 2017. [Cited 14 Jul 2017]. Available at: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.National Comprehensive Cancer Network Guideline for Non-Small Cell Lung Cancerversion 82017[Cited 14 Jul 2017]. Available athttps://www.nccn.org/professionals/physician_gls/pdf/nscl.pdfSearch in Google Scholar
Baker S, Dahele M, Lagerwaard FJ, Senan S. A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiat Oncol 2016; 11: 115. 10.1186/s13014-016-0693-8BakerSDaheleMLagerwaardFJSenanS.A critical review of recent developments in radiotherapy for non-small cell lung cancerRadiat Oncol20161111510.1186/s13014-016-0693-8Open DOISearch in Google Scholar
Ricardi U, Badellino S, Filippi AR. Stereotactic body radiotherapy for early stage lung cancer: history and updated role. Lung Cancer 2015; 90: 388-96. 10.1016/j.lungcan.2015.10.016RicardiUBadellinoSFilippiAR.Stereotactic body radiotherapy for early stage lung cancer: history and updated roleLung Cancer2015903889610.1016/j.lungcan.2015.10.016Open DOISearch in Google Scholar
Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, et al. Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 2014; 190: 26-33. 10.1007/s00066-013-0450-yGuckenbergerMAndratschkeNAlheitHHolyRMoustakisCNestleUDefinition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancerStrahlenther Onkol2014190263310.1007/s00066-013-0450-yOpen DOISearch in Google Scholar
Murray P, Franks K, Hanna GG. A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer. Br J Radiol 2017; 90: 20160732. 10.1259/bjr.20160732MurrayPFranksKHannaGG.A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancerBr J Radiol2017902016073210.1259/bjr.20160732Open DOISearch in Google Scholar
Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303: 1070-6. 10.1001/jama.2010.261TimmermanRPaulusRGalvinJMichalskiJStraubeWBradleyJStereotactic body radiation therapy for inoperable early stage lungancerJAMA20103031070610.1001/jama.2010.261Open DOISearch in Google Scholar
Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2015; 16: 630-7. 10.1016/S1470-2045(15)70168-3ChangJYSenanSPaulMAMehranRJLouieAVBalterPStereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsLancet Oncol201516630710.1016/S1470-2045(15)70168-3Open DOISearch in Google Scholar
Dionisi F, Guarneri A, Dell’Acqua V, Leonardi M, Niespolo R, Macchia G, et al. Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology. Radiol Med 2016; 121: 735-43. 10.1007/s11547-016-0650-5DionisiFGuarneriADell’AcquaVLeonardiMNiespoloRMacchiaGRadiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation OncologyRadiol Med20161217354310.1007/s11547-016-0650-527255503Open DOISearch in Google Scholar
Matsuo Y, Yoshida K, Nishimura H, Ejima Y, Miyawaki D, Uezono H, et al. Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy. J Radiat Res 2016; 57: 512-23. 10.1093/jrr/rrw028MatsuoYYoshidaKNishimuraHEjimaYMiyawakiDUezonoHEfficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapyJ Radiat Res2016575122310.1093/jrr/rrw028504507127053259Open DOISearch in Google Scholar
Nyman J, Hallqvist A, Lund J, Brustugun OT, Bergman B, Bergström P, et al. SPACE - a randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother Oncol 2016; 121: 1-8. 10.1016/j.radonc.2016.08.015NymanJHallqvistALundJBrustugunOTBergmanBBergströmPSPACE - a randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLCRadiother Oncol20161211810.1016/j.radonc.2016.08.01527600155Open DOISearch in Google Scholar
Wang SW, Ren J, Yan YL, Xue CF, Tan L, Ma XW. Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer. Onco Targets Ther 2016; 9: 4993-5003. 10.2147/OTT.S101125WangSWRenJYanYLXueCFTanLMaXW.Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancerOnco Targets Ther201694993500310.2147/OTT.S101125499339527574441Open DOISearch in Google Scholar
Grutters JP, Kessels AG, Pijls-Johannesma M, De Ruysscher D, Joore MA, Lambin P. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol 2010; 95: 32-40. 10.1016/j.radonc.2009.08.003GruttersJPKesselsAGPijls-JohannesmaMDe RuysscherDJooreMALambinP.Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysisRadiother Oncol201095324010.1016/j.radonc.2009.08.00319733410Open DOISearch in Google Scholar
Jeppesen SS, Schytte T, Jensen HR, Brink C, Hansen O. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates. Acta Oncol 2013; 52: 1552-8. 10.3109/0284186X.2013.813635JeppesenSSSchytteTJensenHRBrinkCHansenO.Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival ratesActa Oncol2013521552810.3109/0284186X.2013.81363523902274Open DOISearch in Google Scholar
Widder J, Postmus D, Ubbels JF, Wiegman EM, Langendijk JA. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Int J Radiat Oncol Biol Phys 2011; 81: e291-7. 10.1016/j.ijrobp.2011.03.052WidderJPostmusDUbbelsJFWiegmanEMLangendijkJA.Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancerInt J Radiat Oncol Biol Phys201181e291710.1016/j.ijrobp.2011.03.05221640503Open DOISearch in Google Scholar
Shirvani SM, Jiang J, Chang JY, Welsh JW, Gomez DR, Swisher S, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys 2012; 84: 1060-70. 10.1016/j.ijrobp.2012.07.2354ShirvaniSMJiangJChangJYWelshJWGomezDRSwisherSComparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderlyInt J Radiat Oncol Biol Phys20128410607010.1016/j.ijrobp.2012.07.2354377642822975611Open DOISearch in Google Scholar
Liu HW, Gabos Z, Ghosh S, Roberts B, Lau H, Kerba M. Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta - A population-based study. Radiother Oncol 2015; 117: 71-6. 10.1016/j.radonc.2015.08.027LiuHWGabosZGhoshSRobertsBLauHKerbaM.Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta - A population-based studyRadiother Oncol201511771610.1016/j.radonc.2015.08.02726349589Open DOISearch in Google Scholar
Lanni TB Jr, Grills IS, Kestin LL, Robertson JM. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer. Am J Clin Oncol 2011; 34: 494-8. 10.1097/COC.0b013e3181ec63aeLanniTB JrGrillsISKestinLLRobertsonJM.Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancerAm J Clin Oncol201134494810.1097/COC.0b013e3181ec63ae20805737Open DOISearch in Google Scholar
Mitera G, Swaminath A, Rudoler D, Seereeram C, Giuliani M, Leighl N, et al. Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage I non-small-cell lung cancer. J Oncol Pract 2014; 10: e130-6. 10.1200/JOP.2013.001206MiteraGSwaminathARudolerDSeereeramCGiulianiMLeighlNCost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage I non-small-cell lung cancerJ Oncol Pract201410e130610.1200/JOP.2013.00120624643574Open DOISearch in Google Scholar
The Health and Welfare Data Science Center database (in Chinese). [Cited 18 Jul 2017]. Available at: http://dep.mohw.gov.tw/DOS/np-2497-113.html.The Health and Welfare Data Science Center database (in Chinese)[Cited 18 Jul 2017]. Available athttp://dep.mohw.gov.tw/DOS/np-2497-113.htmlSearch in Google Scholar
Chiang CJ, You SL, Chen CJ, Yang YW, Lo WC, Lai MS. Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review. Jpn J Clin Oncol 2015; 45: 291-6. 10.1093/jjco/hyu211ChiangCJYouSLChenCJYangYWLoWCLaiMS.Quality assessment and improvement of nationwide cancer registration system in Taiwan: a reviewJpn J Clin Oncol201545291610.1093/jjco/hyu21125601947Open DOISearch in Google Scholar
Universal Health Coverage in Taiwan. [Cited 15 Jul 2017]. Available atUniversal Health Coverage in Taiwan[Cited 15 Jul 2017]. Available atSearch in Google Scholar
https://www.nhi.gov.tw/Resource/webdata/21717_1_UnversalHealthCoverage-2.pdf.https://www.nhi.gov.tw/Resource/webdata/21717_1_UnversalHealthCoverage-2.pdfSearch in Google Scholar
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 2014; 12: 1495-9. 10.1016/j.ijsu.2014.07.013von ElmEAltmanDGEggerMPocockSJGøtzschePCVandenbrouckeJPThe Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studiesInt J Surg2014121495910.1016/j.ijsu.2014.07.01325046131Open DOISearch in Google Scholar
Hsia TC, Tu CY, Fang HY, Liang JA, Li CC, Chien CR. Cost and effectiveness of image-guided radiotherapy for non-operated localized lung cancer: a population-based propensity score-matched analysis. J Thorac Dis 2015; 7: 1643-9. 10.3978/j.issn.2072-1439.2015.09.36HsiaTCTuCYFangHYLiangJALiCCChienCR.Cost and effectiveness of image-guided radiotherapy for non-operated localized lung cancer: a population-based propensity score-matched analysisJ Thorac Dis201571643910.3978/j.issn.2072-1439.2015.09.36459852326543613Open DOISearch in Google Scholar
Chien CR, Pan IW, Tsai YW, Tsai T, Liang JA, Buchholz TA, et al. Radiation therapy after breast-conserving surgery: does hospital surgical volume matter? A population-based study in Taiwan. Int J Radiat Oncol Biol Phys 2012; 82: 43-50. 10.1016/j.ijrobp.2010.09.025ChienCRPanIWTsaiYWTsaiTLiangJABuchholzTARadiation therapy after breast-conserving surgery: does hospital surgical volume matter? A population-based study in TaiwanInt J Radiat Oncol Biol Phys201282435010.1016/j.ijrobp.2010.09.02521075558Open DOISearch in Google Scholar
Jelercic S, Rajer M. The role of PET-CT in radiotherapy planning of solid tumours. Radiol Oncol 2015; 49: 1-9. 10.2478/raon-2013-0071JelercicSRajerM.The role of PET-CT in radiotherapy planning of solid tumoursRadiol Oncol2015491910.2478/raon-2013-0071436260025810695Open DOISearch in Google Scholar
Schroeder MC, Tien YY, Wright K, Halfdanarson TR, Abu-Hejleh T, Brooks JM. Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer. Lung Cancer 2016; 95: 28-34. 10.1016/j.lungcan.2016.02.010SchroederMCTienYYWrightKHalfdanarsonTRAbu-HejlehTBrooksJM.Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancerLung Cancer201695283410.1016/j.lungcan.2016.02.010482376927040848Open DOISearch in Google Scholar
Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med 2014; 33: 1242-58. 10.1002/sim.5984AustinPC.The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experimentsStat Med20143312425810.1002/sim.5984428517924122911Open DOISearch in Google Scholar
Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 2015; 34: 3661-79. 10.1002/sim.6607AustinPCStuartEA.Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studiesStat Med20153436617910.1002/sim.6607462640926238958Open DOISearch in Google Scholar
Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed 2004; 75: 45-9. doi:10.1016/j.cmpb.2003.10.004ColeSRHernánMA.Adjusted survival curves with inverse probability weightsComput Methods Programs Biomed20047545910.1016/j.cmpb.2003.10.00415158046Open DOISearch in Google Scholar
Austin PC. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. Stat Med 2016; 35: 5642-55. 10.1002/sim.7084.AustinPC.Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysisStat Med20163556425510.1002/sim.7084515775827549016Open DOISearch in Google Scholar
VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-Value. Ann Intern Med 2017; 167: 268-74. 10.7326/M16-2607VanderWeeleTJDingP.Sensitivity analysis in observational research: introducing the E-ValueAnn Intern Med20171672687410.7326/M16-260728693043Open DOISearch in Google Scholar
Garrido MM, Kelley AS, Paris J, Roza K, Meier DE, Morrison RS, et al. Methods for constructing and assessing propensity scores. Health Serv Res 2014; 49: 1701-20. 10.1111/1475-6773.12182GarridoMMKelleyASParisJRozaKMeierDEMorrisonRSMethods for constructing and assessing propensity scoresHealth Serv Res20144917012010.1111/1475-6773.12182421305724779867Open DOISearch in Google Scholar
Rosenbaum PR. Reasons for Effects. In: Rosenbaum PR, editor. Design of observational studies (Springer Series in Statistics). New York: Springer; 2010. p. 104-7. 10.1007/978-1-4419-1213-8RosenbaumPR.Reasons for EffectsRosenbaumPRDesign of observational studies (Springer Series in Statistics)New YorkSpringer2010104710.1007/978-1-4419-1213-8Open DOISearch in Google Scholar
Koshy M, Malik R, Weichselbaum RR, Sher DJ. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2015; 91: 344-50. 10.1016/j.ijrobp.2014.10.002KoshyMMalikRWeichselbaumRRSherDJ.Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancerInt J Radiat Oncol Biol Phys2015913445010.1016/j.ijrobp.2014.10.002Open DOISearch in Google Scholar
Chang JY, Bezjak A, Mornex F; IASLC Advanced Radiation Technology Committee. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned. J Thorac Oncol 2015; 10: 577-85. 10.1097/JTO.0000000000000453ChangJYBezjakAMornexFIASLC Advanced Radiation Technology Committee. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learnedJ Thorac Oncol2015105778510.1097/JTO.0000000000000453Open DOISearch in Google Scholar
Ma BB, Hui EP, Mok TS. Population-based differences in treatment outcome following anticancer drug therapies. Lancet Oncol 2010; 11: 75-84. 10.1016/S1470-2045(09)70160-3MaBBHuiEPMokTS.Population-based differences in treatment outcome following anticancer drug therapiesLancet Oncol201011758410.1016/S1470-2045(09)70160-3Open DOISearch in Google Scholar
Wu YL, Zhong W, Wang Q, Xu ST, Mao WM, Wu L, et al. Gefitinib (G) versus vinorelbine+cisplatin (VP) as adjuvant treatment in stage II-IIIA (N1-N2) non-small-cell lung cancer (NSCLC) with EGFR-activating mutation (ADJUVANT): a randomized, Phase III trial (CTONG 1104). [Abstract]. 2017 ASCO Annual Meeting; J Clin Oncol 2017; 35(15 Suppl): 8500. 10.1200/JCO.2017.35.15_suppl.8500WuYLZhongWWangQXuSTMaoWMWuLGefitinib (G) versus vinorelbine+cisplatin (VP) as adjuvant treatment in stage II-IIIA (N1-N2) non-small-cell lung cancer (NSCLC) with EGFR-activating mutation (ADJUVANT): a randomized, Phase III trial (CTONG 1104). [Abstract]. 2017 ASCO Annual Meeting;J Clin Oncol20173515850010.1200/JCO.2017.35.15_suppl.8500Open DOISearch in Google Scholar
